Psyched Wellness (PSYC.C) released data from the National Research Council of Canada (NRC) on studies on the neuroprotective properties of their Amanita muscaria mushroom extract, AME-1. The study kicks…
PSYC.C
Psyched Wellness (PSYC.C) released the results and data from the three month oral toxicity preclinical trial on its amanita muscaria mushroom (AME-1) extract today, and enjoyed a substantial 19%…
Whether you’re curious about taking a psychedelics investment trip or a tie-dyed-in-the-wool public market backer, psychedelics conferences are the best way to keep on top of industry advances and…
Detroit, Michigan city officials announced on Monday that they had decriminalized psychedelics, becoming the latest municipality to pull back on law enforcement when it comes to plant-based mind-manifesting substances….
This week, news from the psychedelic sector has been dominated by patent applications and earnings being released. Here’s the run down of this week’s news. Cybin (CYBN.NE) It’s been…
Death & children’s novels When I think about Amanita Muscaria the first two things that come to mind are death, and children’s novels. Amanita Muscaria is arguably the…
Psyched Wellness (PSYC.C) announced that they have completed extraction of AME-1 and have shipped it to their contract research organization in (CRO) partner labs in Asia. The AME-1 was…
Psyched Wellness (PSYC.C), a life sciences company focused on the production and distribution of functional and psychedelic mushrooms, announced today that it has contracted the Nation Research Council of…
Psyched Wellness (PSYC.C) announced they are initiating their next pre-clinical study on their Amanita Muscaria extract (AME-1) with their Clinical Research Organisation partner KGK Science. This newest study is…
Psyched Wellness (PSYC.C) has signed an additional agreement with its contract research organization partner, KGK Science, to further study the anti inflammatory nature of AME-1. “This is a key…